phosphotyrosine has been researched along with Peritoneal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Chen, H; Ding, N; Du, S; Liu, B; Meng, F; Qian, H; Sha, H; Su, S; Wei, J; Yang, J; Zhang, L; Zhou, S; Zou, Z | 1 |
| Bermudez, E; Everitt, J; Ferriola, PC; Mangum, J; Stewart, W; Walker, C | 1 |
2 other study(ies) available for phosphotyrosine and Peritoneal Neoplasms
| Article | Year |
|---|---|
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer.
Topics: Animals; Antigens, CD; Cadherins; Cell Line, Tumor; Gene Knockout Techniques; Human Umbilical Vein Endothelial Cells; Humans; Immunotherapy; Lymphocytes; Male; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Peritoneal Neoplasms; Phosphatidylethanolamines; Phosphorylation; Phosphotyrosine; Polyethylene Glycols; Programmed Cell Death 1 Receptor; Spheroids, Cellular; Stomach Neoplasms; Subcutaneous Tissue | 2019 |
Autocrine growth stimulation by transforming growth factor alpha in asbestos-transformed rat mesothelial cells.
Topics: Animals; Asbestos, Crocidolite; Blotting, Northern; Cell Division; Cell Line; Cell Line, Transformed; Epidermal Growth Factor; ErbB Receptors; Mesothelioma; Peritoneal Neoplasms; Phosphoproteins; Phosphotyrosine; Radioimmunoassay; Rats; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrosine | 1995 |